Filing Details
- Accession Number:
- 0001019687-14-000490
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-12 19:25:31
- Reporting Period:
- 2014-02-11
- Filing Date:
- 2014-02-12
- Accepted Time:
- 2014-02-12 19:25:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1485003 | Eleven Biotherapeutics Inc. | EBIO | Pharmaceutical Preparations (2834) | 252025616 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square, West Tower 11F, 1-5-1, Otenachi Chiyoda-Ku Tokyo, Japan M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-11 | 219,790 | $10.00 | 219,790 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 1,574,803 | $0.00 | 1,794,593 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 232,105 | $0.00 | 2,026,698 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 60,853 | $0.00 | 2,087,551 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-02-11 | 39,740 | $0.00 | 2,127,291 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2014-02-11 | 1,574,803 | $0.00 | 1,574,803 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2014-02-11 | 232,105 | $0.00 | 232,105 | $0.00 |
| Common Stock | Common Stock Warrant (right to purchase) | Disposition | 2014-02-11 | 61,242 | $0.00 | 60,853 | $0.00 |
| Common Stock | Common Stock Warrant (right to purchase) | Disposition | 2014-02-11 | 39,994 | $0.00 | 39,740 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | M | Direct | ||
| 0 | No | 4 | M | Direct |
Footnotes
- The aggregate number of shares of Issuer's Preferred Stock held by the Reporting Person converted into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares converted into Common Stock on a 1-for-1 basis.
- The Reporting Person exercised warrants to purchase shares of Common Stock by cashless exercise immediately prior to the closing of the Issuer's initial public offering.
Billionaire Hedge Funds
